# Genotype Expression and Phenotype of Endothelial Cells, Carrying an ACVRL1, ENG or SMAD4 Mutation, in Response to BMP9 for the Identification of New Therapeutic Targets in Hereditary Haemorrhagic Telangiectasia

> **NCT05632484** · NA · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 16 (actual)

## Conditions studied

- Hereditary Haemorrhagic Telangiectasia

## Interventions

- **BIOLOGICAL:** Cord blood sampling
- **BIOLOGICAL:** Cord blood sampling
- **BIOLOGICAL:** Cord sampling

## Key facts

- **NCT ID:** NCT05632484
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-10
- **Primary completion:** 2023-05-20
- **Final completion:** 2023-05-20
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05632484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05632484, "Genotype Expression and Phenotype of Endothelial Cells, Carrying an ACVRL1, ENG or SMAD4 Mutation, in Response to BMP9 for the Identification of New Therapeutic Targets in Hereditary Haemorrhagic Telangiectasia". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05632484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*